For The Better

These stocks can protect your investment portfolio if a recession is around the corner.

Here’s how to know how likely you are to meet your financial goals.

These two technology stocks are growing revenue and earnings at above-average market rates.

Now’s the time to start building your future wealth.

This isn’t Berkshire’s most exciting investment, but could be a great fit for income seekers.

The switch to a subscription-based model and a terrific end-market opportunity could send this cloud stock soaring.

These industry pioneers can be long-term contributors to a growth portfolio.

Zoom is an enduring growth story. Sure, it’s “expensive,” but it’s worth paying up for.

Reopening trade aside, e-commerce has a long runway for growth.

Pfizer’s abrocitinib faces some challenges despite encouraging late-stage results for the drug in treating eczema.

Resilient companies are always worth a closer look.

The chipmaker faces a long and painful turnaround.

With yields ranging from 1.8% to 9%, these income stocks will pad seniors’ pockets and allow them to sleep easy at night.

You can go big this month with these three pharmaceutical stocks.

There’s a one-word answer: delta.

This latecomer may come out ahead in one particular area in the long run.

If you haven’t considered a Roth IRA before, now is a great time to do so.

The arguments for these two stocks are compelling.

The likelihood of a market pullback appears to be growing. For long-term investors looking to put their cash to work, that’s a good thing.

Social Security may have to reduce benefits in the future, but there’s no sense in losing sleep over that possibility.